ADUHELM is an amyloid beta-directed antibody indicated for the treatment of Alzheimer\u2019s disease. This indication is approved under accelerated approval based on reduction in amyloid beta plaques observed in patients treated with ADUHELM. Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trial(s).<\/p>\n
If ADUHELM (aducanumab-avwa) injection<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n ADUHELM is indicated for the control of absence (petit mal) epilepsy.\u00a0<\/strong>aducanumab-avwa is approved for absence seizures. aducanumab-avwa is considered the first choice drug for treating absence seizures in part because it lacks the idiosyncratic hepatotoxicity of the alternative anti-absence drug, valproic acid. ADUHELM is indicated for the control of absence (petit mal) epilepsy. If you have any questions about your illness, talk to your doctor<\/p>\n Source Details:\u00a0Patient Information<\/a><\/strong><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import ADUHELM (aducanumab-avwa) injection\u201d <\/strong> based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
ADUHELM (aducanumab-avwa) injection<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n ADUHELM<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n aducanumab-avwa<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Injection:
\n\u2022 170 mg\/1.7 mL (100 mg\/mL) solution in a single-dose vial
\n\u2022 300 mg\/3 mL (100 mg\/mL) solution in a single-dose vial<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n \u00a0Biogen<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n